NCT06989086 - FearLess in NeuroOncology | Biotech Hunter

Enrollment

112

Participants

Timeline

Start Date

June 24, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions

Primary Malignant Brain TumorGlioblastoma (GBM)AstrocytomaOligodendrogliomaCaregiver

Interventions

BEHAVIORAL

Fearless in Neuro-Oncology

FearLess is a newly developed, empirically-rooted, manualized psychological intervention consisting of an intake + 8 sessions delivered over a 12-week time period. It consists of weekly individual 60- to 90-minute virtual therapy sessions.

Trial Locations (1)

23298

RECRUITING

Virginia Commonwealth University, Richmond

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Brain Tumor Society

UNKNOWN

lead

Virginia Commonwealth University

OTHER